Active, not recruitingPHASE1, PHASE2NCT04783181

A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)

Studying Congenital adrenal hyperplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Adrenas Therapeutics Inc
Intervention
AAV BBP-631(biological)
Enrollment
8 enrolled
Eligibility
18 years · All sexes
Timeline
20212029

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04783181 on ClinicalTrials.gov

Other trials for Congenital adrenal hyperplasia

Additional recruiting or active studies for the same condition.

See all trials for Congenital adrenal hyperplasia

← Back to all trials